Given the elevated levels of SAG, 2-AG, and ARA observed in mouse melanomas, along with the detection of active Ces1 isoforms in both melanoma and skin tissues, we next evaluated the effects of in vivo Ces1 inhibition on melanoma progression. The gene discussed is CES1; the disease is melanoma.